Shogo Kotsuka

Direttore/Membro del Consiglio presso Biomedica Solution KK

46 anni

Health Technology

Technology Services

Profilo

Shogo Kotsuka is currently a Director at Biomedica Solution KK since 2014.
Prior to this, he worked as a Director & GM-Business Planning Administration at tella, Inc. from 2016 to 2017 and as a Director at Titan, Inc. (Japan).

Posizioni attive di Shogo Kotsuka

Società	Posizione	Inizio
Biomedica Solution KK Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities.	Direttore/Membro del Consiglio	01/02/2014

Tutte le posizioni attive di Shogo Kotsuka

Precedenti posizioni note di Shogo Kotsuka

Società	Posizione	Fine
Titan, Inc. (Japan) Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan.	Direttore/Membro del Consiglio	-
TELLA, INC.	Direttore Finanziario/CFO	-

Vedi nel dettaglio l'esperienza di Shogo Kotsuka

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Shogo Kotsuka

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Titan, Inc. (Japan) Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan.	Technology Services
Biomedica Solution KK Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities.	Health Technology
tella, Inc. tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.	Health Technology

Vedi le connessioni aziendali

Borsa valori
Insiders
Shogo Kotsuka